These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37827848)

  • 1. Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis.
    Yang JH; Liu EN; Nguyen L; Dunn-Pirio A; Graves JS
    Neurology; 2023 Nov; 101(22):e2300-e2313. PubMed ID: 37827848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
    Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
    Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
    JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.
    Wang BJ; Wang CJ; Zeng ZL; Yang Y; Guo SG
    J Neurol Sci; 2017 Jun; 377():127-132. PubMed ID: 28477682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of 173 pediatric patients with antibody-mediated autoimmune diseases of the central nervous system: a single-center cohort study.
    Kang Q; Liao H; Yang L; Fang H; Ning Z; Liao C; Gan S; Wu L
    Front Immunol; 2023; 14():1140872. PubMed ID: 37153594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-NMDAR Encephalitis with Poor Recovery on Steroid Pulse and IVIg: Practical Approach to Intensive Immunotherapy].
    Hara M; Nakajima H
    Brain Nerve; 2022 May; 74(5):433-442. PubMed ID: 35589628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
    Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
    Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
    Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
    Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 10. Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies.
    Du Y; Zhao C; Liu J; Li C; Yan Q; Li L; Hao Y; Yao D; Si H; Zhao Y; Zhang W
    J Neuroinflammation; 2022 Oct; 19(1):259. PubMed ID: 36273158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
    Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study.
    Li Y; Luo H; Zheng Y; Zhou L; Jiang Y; Li X; Ma J; Jiang L
    Mult Scler Relat Disord; 2023 Dec; 80():105063. PubMed ID: 37913674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
    Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
    Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.
    Nan D; Zhang Y; Han J; Jin T
    Neurol Sci; 2021 Mar; 42(3):847-855. PubMed ID: 33409829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure Evolution and Outcome in Pediatric Autoimmune Encephalitis.
    Woo H; Shim Y; Chae JH; Kim KJ; Lim BC
    Pediatr Neurol; 2023 Feb; 139():35-42. PubMed ID: 36508881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study.
    Zhong R; Chen Q; Zhang X; Zhang H; Lin W
    Front Immunol; 2022; 13():918396. PubMed ID: 35757705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line immunotherapy and functional outcomes in autoimmune encephalitis: A systematic review and individual patient data meta-analysis.
    Halliday A; Duncan A; Cheung M; Boston RC; Apiwattanakul M; Camacho X; Bowden S; D'Souza W
    Epilepsia; 2022 Sep; 63(9):2214-2224. PubMed ID: 35700069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis.
    Nosadini M; Thomas T; Eyre M; Anlar B; Armangue T; Benseler SM; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK; Irani SR; Dalmau J; Lim M; Dale RC
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Autoimmune Encephalitis: Case Series From Two Chinese Tertiary Pediatric Neurology Centers.
    Zhang J; Ji T; Chen Q; Jiang Y; Cheng H; Zheng P; Ma W; Lei T; Zhang Y; Jin Y; Wei C; Wu Y; Chang X; Bao X; Zhang Y; Xiong H; Ji X; Feng S; Ren H; Yang J; Jiang Y
    Front Neurol; 2019; 10():906. PubMed ID: 31507515
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapies for Anti-N-M-methyl-D-aspartate Receptor Encephalitis: Multicenter Retrospective Pediatric Cohort Study in China.
    Guang S; Ma J; Ren X; Zhou S; Yang J; Zhang J; Cao X; Zhong L; Ding X; Wang X; Ren C; Zhang W; Zhang L; Zhang M; Sun J; Kessi M; Yin F; Peng J; Jiang Y
    Front Pediatr; 2021; 9():691599. PubMed ID: 34268281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.